Fiche du document
2013
- doi: 10.1186/1479-5876-11-2
- issn: 1479-5876
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1186/1479-5876-11-2
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/23289983
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1479-5876
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_24E72A1EEBF51
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Therapeutic immunologyCiter ce document
A. Bot et al., « JTM's Tumor immunology goes broad: announcing the Immunobiology and Immunotherapy section. », Serveur académique Lausannois, ID : 10.1186/1479-5876-11-2
Métriques
Partage / Export
Résumé
For the last four years the Journal of Translational Medicine (JTM) has hosted the Section of Tumor Immunology and Biological Cancer Therapy. Under the editorial leadership of Dr. Pedro Romero and with the direct support of the Society for Immunotherapy of Cancer (SITC), this section enriched the communication between basic immunological sciences and the clinical investigation arena in oncology. We are re-launching this Section of JTM, now entitled Immunobiology and Immunotherapy, succeeding Tumor Immunology and Biological Cancer Therapy. While aiming to build on the editorial success and focus of its predecessor, this novel Section will have a broader scope, hosting translational immunology topics pertaining to immunotherapy beyond oncology, including disciplines such as inflammation, autoimmunity, transplantation, metabolic disorders and others. As the vision of this re-launched Section of JTM broadens up to serve a communication need for translational immunologists involved with immunotherapy irrespectively of the therapeutic area, a novel and focused journal entitled Journal for Immunotherapy of Cancer (JITC) has just been initiated, sponsored by the SITC.